Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO
· Real-Time Price · USD
1.98
-0.06 (-2.94%)
At close: Aug 15, 2025, 3:59 PM
2.02
2.28%
After-hours: Aug 15, 2025, 07:41 PM EDT
Aptevo Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | 902K | 902K | 902K | 902K | -3.11M | -3.11M | -3.11M | n/a | 6.78M | 9.88M | 12.98M | 12.29M | 11M | 9.37M | 6.73M |
Cost of Revenue | 235K | 277K | 322K | 367K | 436K | 495K | 567K | 612K | 711K | 4.43M | 4.49M | 8.87M | 13.02M | 13.87M | 18.99M | 19.36M | 19.49M | 19.21M |
Gross Profit | -235K | -80K | -125K | 732K | 663K | 407K | 335K | -3.73M | -3.83M | -7.54M | -4.49M | -2.09M | -3.14M | -889K | -6.7M | -8.36M | -10.12M | -12.48M |
Operating Income | -24.3M | -24.1M | -24.6M | -24.6M | -25.95M | -28.11M | -28.88M | -30.18M | -31.4M | -30.79M | -28.64M | -25M | -21.96M | -20.12M | -21.4M | -24.18M | -25.68M | -27.23M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -24.02M | -23.7M | -24.13M | -24.01M | -25.25M | -27.31M | -18.65M | -17.62M | -19.09M | 16.72M | 7.01M | 5.58M | 6.31M | -29.61M | -29.41M | -29.98M | -29.85M | -28.59M |
Net Income | -24.02M | -23.7M | -24.13M | -23.72M | -24.95M | -27.02M | -8.78M | 27.48M | 26.14M | 62.1M | 40.73M | 4.11M | 4.78M | -31.16M | -28.46M | -29.24M | -29.03M | -27.9M |
Selling & General & Admin | 10.36M | 9.84M | 10.22M | 10.52M | 11.08M | 11.41M | 11.77M | 11.99M | 12.62M | 13.6M | 13.87M | 14.03M | 14.2M | 14.61M | 14.7M | 15.82M | 15.55M | 14.28M |
Research & Development | 13.94M | 14.26M | 14.27M | 13.87M | 14.65M | 16.47M | 16.99M | 18.19M | 18.78M | 17.18M | 17.88M | 17.75M | 17.64M | 18.5M | 18.99M | 19.36M | 19.49M | 19.21M |
Other Expenses | -142K | -142K | -71K | n/a | 227K | 457K | 390K | 2.91M | 2.66M | 37.85M | 35.66M | 30.58M | 28.27M | -9.49M | -8.01M | -5.8M | -4.18M | -1.83M |
Operating Expenses | 24.16M | 23.87M | 24.33M | 24.29M | 25.64M | 27.88M | 28.76M | 30.18M | 31.4M | 30.79M | 31.75M | 31.78M | 31.84M | 33.11M | 33.69M | 35.18M | 35.04M | 33.49M |
Interest Expense | n/a | n/a | n/a | 9.58M | 9.58M | 9.58M | 9.58M | n/a | 25K | 25K | 2.29M | 2.29M | 2.26M | 2.26M | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 24.3M | 24.1M | 24.6M | 24.6M | 25.95M | 28.11M | 28.88M | 30.18M | 31.4M | 30.79M | 31.75M | 31.78M | 31.84M | 33.11M | 33.69M | 35.18M | 35.04M | 33.49M |
Income Tax Expense | n/a | n/a | 62.72K | 62.72K | 62.72K | 90.64K | -9.56M | -45.07M | -45.07M | -45.25M | -33.58M | 1.94M | 1.94M | 2.09M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 738.15K | 72.92K | 72.92K | 14.25K | 4.76K | 928.02 | 597.92 | 386.33 | 199.08 | 215.67 | 198.60 | 156.34 | 154.28 | 151.64 | 150.43 | 150.24 | 139.33 | 135.70 |
Shares Outstanding (Diluted) | 738.15K | 72.92K | 72.92K | 14.25K | 4.76K | 928.02 | 597.92 | 386.33 | 199.08 | 215.67 | 198.60 | 156.34 | 154.28 | 151.64 | 150.43 | 150.24 | 139.33 | 135.70 |
EPS (Basic) | -540.68 | -1.77K | -9.05K | -18.83K | -34.87K | -73.55K | -53.33K | -66.83K | -99.33K | 122.15K | 58.53K | 40.21K | 42.53K | -195.95K | -198.66K | -212.97K | -234.8K | -246.38K |
EPS (Diluted) | -540.68 | -1.77K | -9.05K | -18.83K | -34.87K | -73.55K | -53.33K | -66.83K | -99.33K | 122.15K | 58.53K | 40.21K | 42.53K | -195.95K | -198.66K | -212.97K | -234.8K | -246.38K |
EBITDA | -24.1M | -23.85M | -24.25M | -24.21M | -25.52M | -27.61M | -28.31M | -29.57M | -30.69M | -29.95M | -27.74M | -24M | -20.89M | -19.03M | -20.25M | -22.95M | -24.44M | -25.52M |
EBIT | -24.23M | -24.03M | -24.6M | -24.6M | -25.95M | -28.11M | -28.88M | -30.18M | -31.4M | -30.79M | -28.64M | -25M | -21.96M | -20.12M | -21.4M | -24.18M | -25.68M | -26.76M |
Depreciation & Amortization | 265K | 307K | 352K | 397K | 436K | 495K | 567K | 612K | 711K | 837K | 901K | 1M | 1.07M | 1.1M | 1.14M | 1.23M | 1.23M | 1.24M |